First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males
Clinical trial NCT06094283 · COMPLETED
Trial details
- NCT number
- NCT06094283
- Sponsor
- YourChoice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2024-06-18
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.